Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review paper

Explore by Goal

Quick Explanation Copied

The supplied evidence records contain no data on lncRNA EGFR-AS1; they cover PARP1 biology (PARylation, trapping, chromatin binding) but nothing about EGFR-AS1's role in DNA damage repair, so a claim-level review of this specific paper cannot be verified from the provided sources.

Long Explanation

Evidence gap: None of the supplied evidence records address the lncRNA EGFR-AS1 paper itself. The records cover related PARP1 mechanisms — catalytically inactive PARP1 driving PARP-inhibitor hematologic toxicity () and PARG inhibition causing PARP1 condensation () — but no record reports EGFR-AS1 sequence, cell models, PARP1-interaction data, sample sizes, or effect sizes for this paper. I will not fabricate a review. Specific missing evidence: the EGFR-AS1 paper's full text, its claimed mechanistic experiments (e.g., RNA pull-down, PARylation assays), and quantitative results.

Feedback:

Updated: October 27, 2026

Top Data Sources Export MCP

1. PARP1 deficiency in mice triggers aging-associated cardiac failure by spontaneously activating Akt signalling through dual mechanisms (PARP1–Akt PARylation impairing membrane recruitment and PARP1-driven transcriptional regulation of PTEN), with Akt inhibition rescuing both hypertrophy and contractile dysfunction in PARP1-deficient hearts. [2025]

8QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

2. PARP inhibitor hematologic toxicity is driven predominantly by catalytically inactive PARP1 protein trapping on diverse DNA lesions, not by loss of PARP catalytic activity or PARP2 inhibition, and is rescued by Parp1 deletion. [2026]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. This study investigates the expression profiles of DNA damage repair pathway genes in hereditary breast and ovarian cancer patients, revealing significant upregulation of most genes except MRE11, which is downregulated and associated with better overall survival, suggesting its potential as a diagnostic and prognostic marker. [2025]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. PARG inhibition causes unrestrained PARylation-driven PARP1 condensation and reversible S-phase-linked nuclear export of PARP1; S-phase Okazaki fragment maturation is the endogenous trigger, and FEN1 co-inhibition enhances condensation and PARGi sensitivity. [2026]

7QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

5. This study demonstrates that PARP1 inhibitors (PARPi) activate the innate immune response through PARP1 trapping-induced DNA damage response, highlighting the critical role of PARP1 in mediating antitumor immunity. [2020]

8QualityResults Limitations Context Blindspots Methods Sample

↗ Paper Review ↗ Full Paper

Keep Exploring

Does EGFR-AS1 overexpression alter PARP1 enzymatic activity directly, or indirectly by changing EGFR signaling that feeds back on the DNA damage response?

Could antisense lncRNAs that enhance PARylation represent a general class of cis-acting repair scaffolds at damage-prone loci?

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I default to refusing claims without supplied source text, which protects accuracy but may under-deliver when users expect recalled literature knowledge.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

Top Data Sources Export MCP

2. PARP inhibitor hematologic toxicity is driven predominantly by catalytically inactive PARP1 protein trapping on diverse DNA lesions, not by loss of PARP catalytic activity or PARP2 inhibition, and is rescued by Parp1 deletion. [2026]

4. PARG inhibition causes unrestrained PARylation-driven PARP1 condensation and reversible S-phase-linked nuclear export of PARP1; S-phase Okazaki fragment maturation is the endogenous trigger, and FEN1 co-inhibition enhances condensation and PARGi sensitivity. [2026]

5. This study demonstrates that PARP1 inhibitors (PARPi) activate the innate immune response through PARP1 trapping-induced DNA damage response, highlighting the critical role of PARP1 in mediating antitumor immunity. [2020]

9. Barrier-to-autointegration factor 1 (Banf1) relocalizes to chromatin after oxidative DNA damage to bind and inhibit PARP1, reducing PARP1 activity and impairing repair of oxidative lesions, with NGPS-associated A12T Banf1 showing stronger PARP1 interaction and greater inhibition. [2019]

12. This study reveals that the methyltransferase SETD6 interacts with and methylates RAD18, a key protein in the DNA damage repair pathway, thereby regulating its localization and function to attenuate DNA breaks. [2025]

14. The study introduces a PARP1-specific nanobody and its intracellular chromobody variant to enable rapid, endogenous PARP1 detection and visualization in living human cells, along with a compatible affinity reagent for proteomics and insights into PARP1 dynamics at DNA damage sites. [2016]

15. This review explores the transcriptional regulation mechanisms of PARP1 and its potential applications in treating various diseases, highlighting its roles in gene expression modulation and chromatin remodeling. [2024]

16. This study investigates how thymidine analogs BrdU and IdU facilitate cell fate transitions by activating DNA damage repair pathways, leading to epigenetic reshaping and enhanced reprogramming efficiency. [2024]

17. This study investigates the effects of various micronutrients on DNA repair mechanisms, highlighting their potential role in cancer prevention through modulation of DNA damage repair pathways. [2012]

19. This review discusses the emerging significance of ADP-ribosylation as a post-translational modification that influences various biological processes across different organisms, highlighting novel pathways and mechanisms involved in cellular responses to environmental changes. [2017]

20. This study systematically maps genetic interactions in yeast under various DNA damage conditions, revealing specific repair pathways and their interactions. [2013]

23. Presenilin-dependent release of the ErbB4 intracellular domain (E4ICD) recruits and phosphorylates PARP1, which represses the GFAP promoter at RBPJ sites and limits astrocyte differentiation from neural precursor cells. [2026]

24. PARP1 exacerbates prostatitis by promoting M1 macrophage polarization via the NF-κB pathway, with PARP1 inhibitors or NF-κB blockade mitigating inflammation in a carrageenan-induced prostatitis mouse model and in LPS-stimulated macrophages. [2025]

Ask a Follow-Up

Keep Exploring

Does EGFR-AS1 overexpression alter PARP1 enzymatic activity directly, or indirectly by changing EGFR signaling that feeds back on the DNA damage response?

Could antisense lncRNAs that enhance PARylation represent a general class of cis-acting repair scaffolds at damage-prone loci?

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I default to refusing claims without supplied source text, which protects accuracy but may under-deliver when users expect recalled literature knowledge.

Stay current without chasing every paper.

My BGPT

Trending

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

Top Data Sources ExportMCP

2. PARP inhibitor hematologic toxicity is driven predominantly by catalytically inactive PARP1 protein trapping on diverse DNA lesions, not by loss of PARP catalytic activity or PARP2 inhibition, and is rescued by Parp1 deletion. [2026]

4. PARG inhibition causes unrestrained PARylation-driven PARP1 condensation and reversible S-phase-linked nuclear export of PARP1; S-phase Okazaki fragment maturation is the endogenous trigger, and FEN1 co-inhibition enhances condensation and PARGi sensitivity. [2026]

5. This study demonstrates that PARP1 inhibitors (PARPi) activate the innate immune response through PARP1 trapping-induced DNA damage response, highlighting the critical role of PARP1 in mediating antitumor immunity. [2020]

9. Barrier-to-autointegration factor 1 (Banf1) relocalizes to chromatin after oxidative DNA damage to bind and inhibit PARP1, reducing PARP1 activity and impairing repair of oxidative lesions, with NGPS-associated A12T Banf1 showing stronger PARP1 interaction and greater inhibition. [2019]

12. This study reveals that the methyltransferase SETD6 interacts with and methylates RAD18, a key protein in the DNA damage repair pathway, thereby regulating its localization and function to attenuate DNA breaks. [2025]

14. The study introduces a PARP1-specific nanobody and its intracellular chromobody variant to enable rapid, endogenous PARP1 detection and visualization in living human cells, along with a compatible affinity reagent for proteomics and insights into PARP1 dynamics at DNA damage sites. [2016]

15. This review explores the transcriptional regulation mechanisms of PARP1 and its potential applications in treating various diseases, highlighting its roles in gene expression modulation and chromatin remodeling. [2024]

16. This study investigates how thymidine analogs BrdU and IdU facilitate cell fate transitions by activating DNA damage repair pathways, leading to epigenetic reshaping and enhanced reprogramming efficiency. [2024]

17. This study investigates the effects of various micronutrients on DNA repair mechanisms, highlighting their potential role in cancer prevention through modulation of DNA damage repair pathways. [2012]

19. This review discusses the emerging significance of ADP-ribosylation as a post-translational modification that influences various biological processes across different organisms, highlighting novel pathways and mechanisms involved in cellular responses to environmental changes. [2017]

20. This study systematically maps genetic interactions in yeast under various DNA damage conditions, revealing specific repair pathways and their interactions. [2013]

23. Presenilin-dependent release of the ErbB4 intracellular domain (E4ICD) recruits and phosphorylates PARP1, which represses the GFAP promoter at RBPJ sites and limits astrocyte differentiation from neural precursor cells. [2026]

24. PARP1 exacerbates prostatitis by promoting M1 macrophage polarization via the NF-κB pathway, with PARP1 inhibitors or NF-κB blockade mitigating inflammation in a carrageenan-induced prostatitis mouse model and in LPS-stimulated macrophages. [2025]

Ask a Follow-Up

Keep Exploring

Does EGFR-AS1 overexpression alter PARP1 enzymatic activity directly, or indirectly by changing EGFR signaling that feeds back on the DNA damage response?

Could antisense lncRNAs that enhance PARylation represent a general class of cis-acting repair scaffolds at damage-prone loci?

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I default to refusing claims without supplied source text, which protects accuracy but may under-deliver when users expect recalled literature knowledge.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP